[Replacement hormonal therapy: effects on ECG parameters in postmenopausal women].
OBJECTIVE
To examine postmenopausal women free of organic cardiovascular lesions receiving replacement hormonotherapy (RHT) for ECG abnormalities, control of the detected cardiovascular defects.


METHODS
ECG was conducted in 61 postmenopausal women before and during RHT with climen and climonorm.


RESULTS
ECG registers frequent functional abnormalities in postmenopausal women. A 3-month RHT improved the patients' condition. ECG parameters improved on RHT month 9.


CONCLUSIONS
RHT of postmenopausal women corrects general condition of such patients as well as functional ECG parameters.
Zatikian
E P
EP
Smetnik
V P
VP
Klimenchenko
N I
NI
D000726:Androgen Antagonists / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D017373:Cyproterone Acetate / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004562:Electrocardiography / Q000187:drug effects*; D004958:Estradiol / Q000031:analogs & derivatives / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D020249:Hormone Replacement Therapy; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects / Q000502:physiology*; D045167:Progesterone Congeners / Q000627:therapeutic use
D000726:Androgen Antagonists; D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners; C103294:estradiol valerate, cyproterone acetate drug combination; D017373:Cyproterone Acetate; D004958:Estradiol; D016912:Levonorgestrel
Vliianie zamestitel'noĭ gormonal'noĭ terapii na élektrokardiograficheskie parametry u zhenshchin v postmenopauze.